Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting a new life by joining Regeneron Genetics Center, a Regeneron subsidiary that analyzes genetic data for drug R&D. The post 23andMe Bankruptcy Auction Win Adds…
ZEM Life is developing a smartwatch that can deliver Narcan to combat a fentanyl overdose. The post How One Company Aims to Save Lives with Its Smartwatch appeared first on MedCity News.
To scale clinical AI, vendors must design tools that feel natural and personalized to each doctor — otherwise, clinicians won’t use them, said Heidi Health CEO Tom Kelly. In the crowded AI scribe market, he believes that clinician adoption rates, not flashy integration or deployment speeds, are the true measure of success. The post How…
We need to evaluate agentic AI through the specific lens of the healthcare industry and its workflows, evaluating the needs of providers, healthcare organizations as well as patients, recognizing that healthcare is not monolithic and will have workflows that are more appropriate than others for implementing AI. The post Why Agentic AI Is Not Quite…
[Sponsored] Get your IV treatment from wherever you are. These top companies provide mobile IV therapy administered by experienced nurses in NYC and beyond. The post 5 Companies That Offer Mobile IV Therapy With Experienced Nurses in NYC and Beyond appeared first on MedCity News.
Today’s healthcare industry is evolving, which highlights the essential need to adapt and adopt new technologies. Organizations that fully commit to digital transformation, prioritize robust data literacy and focus on pragmatic use cases for AI will unlock AI’s true potential. The post The Influence of Digital Transformation and AI in the Future of Life Sciences…
[Sponsored] In an interview with MedCity News, Smarter Technologies CEO Jeremy Delinsky talked about the newly formed business Smarter Technologies and his ambition to automate hospitals’ revenue management capabilities with AI, which lags 2-5 years behind that of payers. The post How Smarter AI Strikes Back for Hospitals appeared first on MedCity News.
Apnimed’s obstructive sleep apnea drug reduced breathing interruptions in a Phase 3 clinical trial. The once-nightly pill, which is based on research from Brigham and Women’s Hospital, activates muscles that keep the upper airway open during sleep. The post Sleep Apnea Relief in a Pill: Apnimed Drug’s Phase 3 Data Set Stage for FDA Submission…
Ensuring buy-in from end users is critical to hospitals’ AI success. To achieve buy-in, hospitals should start by adopting AI tools that address the problems that physicians and nurses have identified as most important to them, said Rohit Chandra, chief digital officer at Cleveland Clinic. The post Cleveland Clinic Digital Chief: Pick AI Problems That…
Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies. The post Alzheimer’s Disease Now Has Its First FDA-Cleared Blood Test appeared first on MedCity News.